Author:
Undurraga Juan,Baldessarini Ross J
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference135 articles.
1. Amsterdam JD (2003). Double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder. J Clin Psychiatry 64: 208–214.
2. Anderson B (1990). Methodological Errors in Medical Research: Incomplete Catalog. Blackwell: New York.
3. Anderson IM (2001). Meta-analytical studies on new antidepressants. Br Med Bull 57: 161–178.
4. Andreoli V, Caillard V, Deo RS, Rybakowski JK, Versiani M (2002). Reboxetine, new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression. J Clin Psychopharmacol 22: 393–399.
5. Baldessarini RJ (2005). Drug therapy of depression and anxiety disorders. Chapter 17. In: Brunton LL, Lazo JS, Parker KL (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics, 11th edn. McGraw-Hill: New York, pp 429–459.
Cited by
200 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献